![Nathalie Harroy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nathalie Harroy
No open positions remaining
Profile
Nathalie Harroy worked as Chief Human Resources Officer at Abbott Laboratories Co. from 2010 to 2012.
Ms. Harroy worked as Head-Human Resources at Inventiva SA from 2012 to 2026.
Ms. Harroy worked as Senior Vice President-Research Division at Laboratoires Fournier SAS. Ms. Harroy completed undergraduate studies at Conservatoire National des Arts et Métiers.
Former positions of Nathalie Harroy
| Companies | Position | End |
|---|---|---|
| INVENTIVA | Human Resources Officer | 2026-04-21 |
Abbott Laboratories Co.
 Abbott Laboratories Co. Pharmaceuticals: MajorHealth Technology Manufactures and distributes nutritional products, diagnostic tools and vascular devices | Human Resources Officer | 2011-12-31 |
Laboratoires Fournier SAS
 Laboratoires Fournier SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Corporate Officer/Principal | - |
Training of Nathalie Harroy
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
32
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Laboratoires Fournier SAS
Laboratoires Fournier SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Health Technology |
Conservatoire National des Arts et Métiers
 Conservatoire National des Arts et Métiers Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abbott Laboratories Co.
Abbott Laboratories Co. Pharmaceuticals: MajorHealth Technology Manufactures and distributes nutritional products, diagnostic tools and vascular devices | Health Technology |
Inventiva SA
 Inventiva SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops oral small molecule therapies for the treatment of MASH and other diseases | Health Technology |
- Stock Market
- Insiders
- Nathalie Harroy
